Ten percent of people in the trial had this dramatic response that was shown here, and the drug went to the FDA, and the FDA said, "" Without a placebo, how do I know patients actually benefited from the drug? "" So the morning the FDA was going to meet, this was the editorial in the Wall Street Journal.